Key result
ADAS discriminates Alzheimer's dementia from healthy controls with 100% accuracy, outperforming EEG.
Why the study?
The validity of neuropsychometric tests like ADAS and EEG in discriminating dementia of the Alzheimer type from healthy controls is poorly investigated.
Do ADAS and EEG accurately discriminate patients with dementia of the Alzheimer type from healthy controls?
Case-Control (n=80)
Do ADAS and EEG accurately discriminate patients with dementia of the Alzheimer type from healthy controls?
Absolute Event Rate: 100% vs 90%
Both ADAS and EEG provide excellent and complementary discrimination between healthy controls and patients with Alzheimer's dementia.
Supports diagnostic utility of ADAS and EEG; hypothesis-generating and requires prospective validation before clinical use.
Neuropsychometric tests (for instance the Alzheimer's Disease Assessment Scale, ADAS) and the EEG are often used in the diagnostic procedure of dementia. The validity of the instruments is only poorly investigated. The study aimed to investigate the accuracy of the discrimination between healthy controls and patients with dementia of the Alzheimer type (DAT) by ADAS and EEG. Thirty-six patients with DAT and 44 healthy controls were included. In a discriminant analysis of the 21 ADAS items and 18 EEG parameters (6 frequency bands, 12 topographic parameters), 6 ADAS items turned out to discriminate both groups with 100% sensitivity and specificity (remembering instructions, depression, following commands, pacing, restlessness and word finding difficulties). Regarding EEG parameters, 4 (topography of beta- and delta-activity and amplitude of delta-activity) led to a sensitivity and specificity of over 90%. Thus, both methods demonstrated an excellent discrimination between healthy controls and DAT. The slightly higher discrimination with the ADAS may depend on its closer relation to clinical symptoms. However, the EEG measuring functional activity reached nearly the same result. Both methods provide complementary information. A combination of both methods in the diagnostic procedure to detect dementia is recommended.
No takes yet. Share an insight, caveat, or question.
Ihl et al. (2000) conducted a case-control in Dementia of the Alzheimer type (n=80). Alzheimer's Disease Assessment Scale (ADAS) and EEG was evaluated on Discrimination between healthy controls and patients with DAT (sensitivity and specificity). ADAS discriminated patients with Alzheimer's dementia from healthy controls with 100% sensitivity and specificity, while EEG achieved over 90% sensitivity and specificity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: